Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

RNF13 Activators

The chemical class known as RNF13 Activators encompasses a diverse group of compounds that can activate the RNF13 protein, a RING-type E3 ubiquitin ligase involved in various cellular processes. These activators can provoke a cellular environment that necessitates the ubiquitin-proteasome system (UPS), where RNF13 plays a critical role. By influencing the UPS, these chemicals can enhance the function of RNF13, leading to an increased ubiquitination of proteins that are subsequently directed towards degradation. The activation of RNF13 by these chemicals is not a direct interaction but rather an upregulation of its activity in response to cellular stressors, such as ER stress, disrupted protein trafficking, and proteasome inhibition.

The mechanisms by which these activators work involve inducing stress within the endoplasmic reticulum, inhibiting key cellular functions, or blocking degradation pathways, thereby creating a cellular demand for the homeostatic functions of RNF13. This demand can result in an upsurge in the activity of RNF13 to restore balance within the cell. For instance, when proteasome function is inhibited, proteins tagged for degradation accumulate, and RNF13's role becomes crucial to manage this protein load. Similarly, when ER stress is induced, the unfolded protein response is activated, and RNF13 may be upregulated to help mitigate the stress by directing misfolded proteins for degradation. Through these varied mechanisms, RNF13 activators can lead to an increase in the ubiquitin-ligase activity of RNF13, thereby affecting the turnover of proteins within the cell and facilitating the maintenance of cellular homeostasis.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

Disrupts ER-Golgi transport, which can lead to ER stress and may enhance RNF13-mediated degradation pathways.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

A proteasome inhibitor that leads to the accumulation of ubiquitinated proteins, which could possibly activate RNF13's E3 ligase activity due to increased demand.

Salubrinal

405060-95-9sc-202332
sc-202332A
1 mg
5 mg
$34.00
$104.00
87
(2)

Selectively inhibits dephosphorylation of eIF2α, leading to an ER stress response, which could possibly activate RNF13.

Z-VAD-FMK

187389-52-2sc-3067
500 µg
$75.00
256
(6)

A pan-caspase inhibitor that blocks apoptosis, potentially affecting the turnover of apoptotic regulatory proteins and could possibly activate RNF13.

β-Lapachone

4707-32-8sc-200875
sc-200875A
5 mg
25 mg
$112.00
$459.00
8
(1)

Promotes oxidative stress and induces ER stress, which could possibly activate RNF13-mediated ERAD.

17-AAG

75747-14-7sc-200641
sc-200641A
1 mg
5 mg
$67.00
$156.00
16
(2)

An Hsp90 inhibitor that causes the degradation of client proteins and induces ER stress, which could possibly activate RNF13.

Lactacystin

133343-34-7sc-3575
sc-3575A
200 µg
1 mg
$188.00
$575.00
60
(2)

A proteasome inhibitor that leads to a buildup of polyubiquitinated proteins, which could possibly activate RNF13's E3 ligase activity as the cell attempts to manage the increased protein load.